Mereo BioPharma Group plc SEC filings MREO
Mereo BioPharma Group plc has 439 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Feb 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 9, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 6, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 4, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 25, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 25, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 25, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 25, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 144 | Notice of proposed sale | Sep 12, 2024 | — |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 144 | Notice of proposed sale | Aug 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jul 11, 2024 | — |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 21, 2024 |
| 144/A | Filing | Jun 24, 2024 | — |
| 144/A | Filing | Jun 24, 2024 | — |
| 144/A | Filing | Jun 24, 2024 | — |
| 144/A | Filing | Jun 24, 2024 | — |
| 144/A | Filing | Jun 24, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 4 | Insider transaction | Jun 17, 2024 | Jun 17, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 17, 2024 | — |
| 4 | Insider transaction | Jun 17, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 17, 2024 |
| 4/A | Filing | Jun 11, 2024 | May 22, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 22, 2024 |
| 144 | Notice of proposed sale | May 23, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Apr 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 5, 2024 | — |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 25, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 20, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 15, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 13, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 8, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 6, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 2, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 31, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Jul 26, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 16, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 28, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 23, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 24, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 14, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 9, 2022 | — |
| SC 13D | Ownership over 5% (active) | May 26, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 15, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 2, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Mar 1, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 19, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jul 10, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jul 2, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jun 12, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 5, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Mar 9, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Mar 2, 2020 | — |
| SC 13D | Ownership over 5% (active) | Dec 17, 2018 | — |
Showing 179 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MREO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1719714
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.